Skip to main content

Research Repository

Advanced Search

All Outputs (16)

OA18 Measuring fatigue in axial spondyloarthritis: refinement and evaluation of the electronic version of the Warwick Axial Spondyloarthritis Fatigue and Energy questionnaire (2025)
Presentation / Conference Contribution
Prior, J. A., Parsons, H., Tajuria, G., Tutton, E., Strickland, G., Thompson, J., Pearson, N., Packham, J., & Haywood, K. (2025, April). OA18 Measuring fatigue in axial spondyloarthritis: refinement and evaluation of the electronic version of the Warwick Axial Spondyloarthritis Fatigue and Energy questionnaire. Presented at British Society for Rheumatology Annual Conference, Manchester Central Convention Complex, Manchester, England

Background/Aims Axial spondyloarthritis (axSpA) is a chronic inflammatory condition of the axial skeleton and peripheral joints. Though typified by back pain and stiffness, disrupted sleep and fatigue are commonly experienced and ranked as major burd... Read More about OA18 Measuring fatigue in axial spondyloarthritis: refinement and evaluation of the electronic version of the Warwick Axial Spondyloarthritis Fatigue and Energy questionnaire.

P087 Cardioprotective effects of colchicine in people with gout: a systematic review (2025)
Presentation / Conference Contribution
Prior, J. A., Umar, Z., Ibrahim, N., Bajpai, R., Partington, R., Mamas, M., & Roddy, E. (2025, April). P087 Cardioprotective effects of colchicine in people with gout: a systematic review. Poster presented at British Society for Rheumatology Annual Conference 2025, Manchester Central Convention Complex, Manchester, England UK

Background/Aims Colchicine is widely used in clinical practice to prevent and treat gout flares. Randomised controlled trials (RCT) have demonstrated cardiovascular benefits of colchicine in people with chronic coronary artery disease (CAD) or a rece... Read More about P087 Cardioprotective effects of colchicine in people with gout: a systematic review.

E096 Sexual function in axial spondyloarthritis: a systematic review and meta-analysis (2025)
Presentation / Conference Contribution
Somer, M., Battista, S., Grange, J., Prior, Y., Parsons, H., Packham, J., Haywood, K., & Prior, J. (2025, April). E096 Sexual function in axial spondyloarthritis: a systematic review and meta-analysis. Poster presented at British Society for Rheumatology Annual Conference 2025, Manchester Central Convention Complex, Manchester, England, UK

Background/Aims Sexual function is crucial for fostering intimate relationships and enhancing quality of life. The impact of axial spondyloarthritis (axSpA) on sexual function remains unclear despite existing research, which has typically focused on... Read More about E096 Sexual function in axial spondyloarthritis: a systematic review and meta-analysis.

O40 Trends in incidence of GCA in the UK (2020)
Presentation / Conference Contribution
Barnett, L. A., Helliwell, T., Jordan, K., & Prior, J. O40 Trends in incidence of GCA in the UK. Presented at British Society for Rheumatology Annual Conference 2020

Background
Giant cell arteritis (GCA) is the most common form of medium and large vessel vasculitis. Diagnosis remains difficult since there are a multitude of symptoms experienced by patients with GCA and if not promptly identified or treated, pati... Read More about O40 Trends in incidence of GCA in the UK.

INCREASED RISK OF SELF-HARM IN PATIENTS WITH OSTEOPOROSIS: A UK POPULATION STUDY (2018)
Presentation / Conference Contribution
Prior, J., Whittle, R., Abdul-Sultan, A., Chew-Graham, C., Sumathipala, A., Sheperd, T., Mallen, C., & Paskins, Z. (2018, December). INCREASED RISK OF SELF-HARM IN PATIENTS WITH OSTEOPOROSIS: A UK POPULATION STUDY. Poster presented at Osteoporosis Conference 2018, Birmingham, UK

Background: Prevention of self-harm, as a key risk factor for suicide, is an international public health priority. The World Health Organization recommends that clinicians should assess the potential for self-harm in patients in high-risk groups e.g.... Read More about INCREASED RISK OF SELF-HARM IN PATIENTS WITH OSTEOPOROSIS: A UK POPULATION STUDY.

AB0212 Diagnostic delay for rheumatoid arthritis: a systematic review (2018)
Presentation / Conference Contribution
Hay, C., Prior, J., Scott, I., Raza, K., Hider, S., & Mallen, C. (2018, June). AB0212 Diagnostic delay for rheumatoid arthritis: a systematic review. Paper presented at Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, Netherlands

Background Rheumatoid arthritis (RA) is a common inflammatory condition, affecting 1% of the population and causing pain, stiffness and swelling, leading to significant disability and loss of function[.1 Delays in the diagnosis and treatment of RA ca... Read More about AB0212 Diagnostic delay for rheumatoid arthritis: a systematic review.

SAT0708 Symptoms indicative of inflammatory arthritis are common in the primary care population: findings from the symptoms in persons at risk of rheumatoid arthritis survey (2017)
Presentation / Conference Contribution
Hider, S., Muller, S., Prior, J., Helliwell, T., Schaardenburg, D. V., Mil, A. V. D. H.-V., Raza, K., & Mallen, C. (2017, June). SAT0708 Symptoms indicative of inflammatory arthritis are common in the primary care population: findings from the symptoms in persons at risk of rheumatoid arthritis survey. Paper presented at Annual European Congress of Rheumatology, 14–17 June, 2017

DIAGNOSTIC DELAY FOR GIANT CELL ARTERITIS (GCA). A SYSTEMATIC REVIEW AND META-ANALYSIS (2016)
Presentation / Conference Contribution
Prior, J. A., Ranjbar, H., Belcher, J., Mackie, S., & Mallen, C. D. DIAGNOSTIC DELAY FOR GIANT CELL ARTERITIS (GCA). A SYSTEMATIC REVIEW AND META-ANALYSIS

Background The diagnosis of giant cell arteritis (GCA) remains difficult, with patients often presenting with non-specific and atypical symptoms. Such ambiguity can lead to delays in the diagnosis of GCA, which in-turn may result in the patient exper... Read More about DIAGNOSTIC DELAY FOR GIANT CELL ARTERITIS (GCA). A SYSTEMATIC REVIEW AND META-ANALYSIS.